/Mckesson%20Corporation%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
With a market cap of $97.9 billion, McKesson Corporation (MCK) is a global leader in healthcare services and information technology. The company operates through four segments: U.S. Pharmaceutical; Prescription Technology Solutions (RxTS); Medical-Surgical Solutions; and International, providing pharmaceutical distribution, medical-surgical supplies, and technology-driven healthcare solutions worldwide.
The Irving, Texas-based company is set to announce its fiscal Q2 2026 results after the market closes on Wednesday, Nov. 5. Ahead of the event, analysts forecast McKesson to post an adjusted EPS of $8.92, a 26.2% growth from $7.07 in the same quarter last year. The company has surpassed Wall Street's bottom-line projections in three of the past four quarters while missing on another occasion.